(Q42063008)

15 October 2017

title

Chemical inhibitors of cyclin-dependent kinases (English)

1 reference

15 October 2017

Meijer L

1

1 reference

15 October 2017

Kim SH

series ordinal

2

1 reference

15 October 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

15 October 2017

published in

Methods in Enzymology

1 reference

15 October 2017

volume

283

1 reference

15 October 2017

page(s)

113-128

1 reference

Principles of CDK regulation

15 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Cyclins and cyclin-dependent kinases: a biochemical view

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Crystal structure of cyclin-dependent kinase 2

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Multiple modes of ligand recognition: crystal structures of cyclin-dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Crystal structure and mutational analysis of the human CDK2 kinase complex with cell cycle-regulatory protein CksHs1

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Structural basis of cyclin-dependent kinase activation by phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Chemical inhibitors of cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Production of p60c-src by baculovirus expression and immunoaffinity purification

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Activation of human cyclin-dependent kinases in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Inhibition of cyclin-dependent kinases by purine analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Initial triggering of M-phase in starfish oocytes: a possible novel component of maturation-promoting factor besides cdc2 kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Inhibition of cyclin-dependent kinases by p21

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

D-type cyclin-dependent kinase activity in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Staurosporine is a potent inhibitor of p34cdc2 and p34cdc2-like kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

UCN-01, 7-hydroxyl-staurosporine, inhibits kinase activity of cyclin-dependent kinases and reduces the phosphorylation of the retinoblastoma susceptibility gene product in A549 human lung cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Inhibition of cell cycle oscillation of DNA replication by a selective inhibitor of the cdc2 kinase family, butyrolactone I, in Xenopus egg extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Growth inhibition with reversible cell cycle arrest of carcinoma cells by flavone L86-8275

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Alteration of the phosphorylation state of p34cdc2 kinase by the flavone L86-8275 in breast carcinoma cells. Correlation with decreased H1 kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Potent inhibition of CDC2 kinase activity by the flavonoid L86-8275.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Effect of suramin on p34cdc2 kinase in vitro and in extracts from human H69 cells: evidence for a double mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Inhibition of p53 Protein Phosphorylation by 9‐Hydroxyellipticine: A Possible Anticancer Mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Olomoucine, an inhibitor of the cdc2/cdk2 kinases activity, blocks plant cells at the G1 to S and G2 to M cell cycle transitions

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Activation of M-phase-specific histone H1 kinase by modification of the phosphorylation of its p34cdc2 and cyclin components

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Facile Preparation of 2,6-Disubstituted Purines Using Solid-Phase Chemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Cleavage inhibition in marine eggs by puromycin and 6-dimethylaminopurine.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Inhibitors of cyclin-dependent kinases promote survival of post-mitotic neuronally differentiated PC12 cells and sympathetic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2983011-X

7 January 2021

Studies on the metabolic products of Aspergillus terreus. III. Metabolites of the strain IFO 8835. 1.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.25.2593

Identifiers

DOI

10.1016/S0076-6879(97)83011-X

1 reference

15 October 2017

1 reference